JLE

Epileptic Disorders

MENU

A case of anti-NMDA receptor encephalitis revealed by insular epilepsy Volume 19, issue 4, December 2017

  • [Bayreuther et al., 2009] Bayreuther C., Bourg V., Dellamonica J., Borg M., Bernardin G., Thomas P. Complex partial status epilepticus revealing anti-NMDA receptor encephalitis. Epileptic Disord. 2009;11:261-265.
  • [Cooray et al., 2015] Cooray G.K., Sengupta B., Douglas P., Englund M., Wickstrom R., Friston K. Characterising seizures in anti-NMDA-receptor encephalitis with dynamic causal modelling. Neuroimage. 2015;118:508-519.
  • [Dalmau et al., 2007] Dalmau J., Tuzun E., Wu H.Y. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61:25-36.
  • [Dalmau et al., 2008] Dalmau J., Gleichman A.J., Hughes E.G. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7:1091-1098.
  • [Dalmau et al., 2011] Dalmau J., Lancaster E., Martinez-Hernandez E., Rosenfeld M.R., Balice-Gordon R. Clinical experience and laboratory investigations in patients with antiNMDAR encephalitis. Lancet Neurol. 2011;10:63-74.
  • [Graus et al., 2016] Graus F., Titulaer M.J., Balu R. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15:391-440.
  • [Hegen et al., 2016] Hegen H., Uprimny C., Grams A. Bi-insular cortical involvement in anti-NMDA-receptor encephalitis: a case report. BMC Neurol. 2016;16:130.
  • [Isnard et al., 2004] Isnard J., Guénot M., Sindou M., Mauguière F. Clinical manifestations of insular lobe seizures: a stereo-electroencephalographic study. Epilepsia. 2004;45:1079-1090.
  • [Kim et al., 2015] Kim H., Ryu H., Kang J.K. Anti-NMDA receptor antibody encephalitis presenting with unilateral non-convulsive status epilepticus in a male patient. J Epilepsy Res. 2015;5:17-19.
  • [Kreye et al., 2016] Kreye J., Wenke N.K., Chayka M. Human cerebrospinal fluid monoclonal N-methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesis. Brain. 2016;139:2641-2652.
  • [Lancaster, 2016] Lancaster E. The diagnosis and treatment of autoimmune encephalitis. J Clin Neurol. 2016;12:1-13.
  • [Leypoldt et al., 2012] Leypoldt F., Buchert R., Kleiter I. Fluorodeoxyglucose positron emission tomography in anti-N-methyl-D-aspartate receptor encephalitis: distinct pattern of disease. J Neurol Neurosurg Psychiatry. 2012;83:681-686.
  • [Novy et al., 2016] Novy J., Allenbach G., Bien C.G., Guedj E., Prior J.O., Rossetti A.O. FDG-PET hyperactivity pattern in anti-NMDAr encephalitis. J Neuroimmunol. 2016;297:156-158.
  • [Probasco et al., 2014] Probasco J.C., Benavides D.R., Ciarallo A. Electroencephalographic and fluorodeoxyglucose-positron emission tomography correlates in anti-N-methyl-d-aspartate receptor autoimmune encephalitis. Epilepsy Behav Case Rep. 2014;2:174-178.
  • [Schmitt et al., 2012] Schmitt S.E., Pargeon K., Frechette E.S., Hirsch L.J., Dalmau J., Friedman D. Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology. 2012;79:1094-1100.
  • [Titulaer and Dalmau, 2014] Titulaer M.J., Dalmau J. Seizures as first symptom of anti-NMDA receptor encephalitis are more common in men. Neurology. 2014;82:550-551.
  • [Veciana et al., 2015] Veciana M., Becerra J.L., Fossas P. EEG extreme delta brush: an ictal pattern in patients with anti-NMDA receptor encephalitis. Epilepsy Behav. 2015;49:280-285.
  • [Wandinger et al., 2009] Wandinger KP, Dalmau J, Borowski K, et al. Recombinant immunofluorescence assay for the detection of anti-glutamate receptor (type NMDA) antibodies in the differential diagnosis of autoimmune encephalopathies. Euroimmun Iift AG, Scientific presentation at the 9th Dresden Symposium on Autoantibodies, Dresden Germany, 2009.